Clariant AG provided earnings guidance for the full year 2022. For the year, the company expects to generate continued strong sales growth in local currency versus the prior year, underpinned by expansion in Care Chemicals and Natural Resources despite a normalizing growth environment.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.01 CHF | +0.07% | +4.09% | +20.85% |
04-30 | Global markets live: Adidas, Mercedes, McDonalds, Eli Lilly, PayPal, MicroStrategy, Tesla... | |
04-30 | Transcript : Clariant AG, Q1 2024 Earnings Call, Apr 30, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.85% | 5.4B | |
+18.13% | 66.91B | |
+3.65% | 49.8B | |
+21.27% | 42.65B | |
+25.23% | 26.61B | |
+10.72% | 19.29B | |
-1.61% | 16.7B | |
+5.48% | 15.94B | |
-11.69% | 15B | |
-29.11% | 14.43B |
- Stock Market
- Equities
- CLN Stock
- News Clariant AG
- Clariant AG Provides Earnings Guidance for the Full Year 2022